2001
DOI: 10.1006/bbrc.2001.5007
|View full text |Cite
|
Sign up to set email alerts
|

Association of the Glu298Asp Polymorphism in the Endothelial Nitric Oxide Synthase Gene with Essential Hypertension Resistant to Conventional Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

5
60
0
1

Year Published

2002
2002
2013
2013

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(66 citation statements)
references
References 37 publications
5
60
0
1
Order By: Relevance
“…Nitric oxide (NO) is known to be able to diffuse from the vascular endothelium to the smooth muscle cells in the vessel wall, where it activates soluble guanylate cyclase, sequentially leading to the relaxation of the vascular smooth muscle cell and to vasodilatation. Recently, increasing evidence suggests that polymorphisms of the endothelial NO synthase (eNOS) gene are associated with human EH, and certain genetic variations have been found among different ethnicities (Miyamoto et al, 1998;Benjafield and , 2000;Jachymova et al, 2001;Zhao et al, 2006;Khawaja et al, 2007;Periaswamy et al, 2008;Srivastava et al, 2008;Tang et al, 2008;Patkar et al, 2009;Li et al, 2011;Li, 2011;Men et al, 2011). eNOS is expressed in the endothelium and is encoded by a gene located on chromosome 7q35-36, comprising 26 exons that span 21 kb (Bonnardeaux et al, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Nitric oxide (NO) is known to be able to diffuse from the vascular endothelium to the smooth muscle cells in the vessel wall, where it activates soluble guanylate cyclase, sequentially leading to the relaxation of the vascular smooth muscle cell and to vasodilatation. Recently, increasing evidence suggests that polymorphisms of the endothelial NO synthase (eNOS) gene are associated with human EH, and certain genetic variations have been found among different ethnicities (Miyamoto et al, 1998;Benjafield and , 2000;Jachymova et al, 2001;Zhao et al, 2006;Khawaja et al, 2007;Periaswamy et al, 2008;Srivastava et al, 2008;Tang et al, 2008;Patkar et al, 2009;Li et al, 2011;Li, 2011;Men et al, 2011). eNOS is expressed in the endothelium and is encoded by a gene located on chromosome 7q35-36, comprising 26 exons that span 21 kb (Bonnardeaux et al, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…This variant has been associated with an array of clinical conditions, including coronary spasm (Nakayama et al 1999), emphysema (Novoradovsky et al 1999), asthma (Grasemann et al 2000) and essential hypertension (Jachymova et al 2001).…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Prevalence of 'true' resistant hypertension (excluding secondary causes of hypertension, white coat hypertension, inadequate doses and so on) is about 5% in the general hypertensive population. 3 A few studies have evaluated genetic determinants of refractory hypertension [4][5][6] but others suggest that it occurs as a result of poor treatment adherence or suboptimal therapy. 1 It has been recently observed that stroke-prone spontaneously hypertensive rats had significantly reduced levels of glutathione S-transferase (GST) (m type 1) M1 expression.…”
mentioning
confidence: 99%